Natixis’s Tenet Healthcare THC Stock Holding History

Natixis’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$802K	Sell	4,250 -26,812	-86%	-$5.65M	﹤0.01%	729
2025 Q4	$6.17M	Buy	31,062 +30,979	+37,324%	+$6.26M	0.02%	419
2025 Q3	$16.9K	Buy	+83	New	+$14.7K	﹤0.01%	974
2025 Q1	–	Sell	-76	Closed	-$9.59K	–	1191
2024 Q4	$9.59K	Sell	76 -17,301	-100%	-$2.57M	﹤0.01%	954
2024 Q3	$2.89M	Buy	+17,377	New	+$2.63M	0.02%	381
2023 Q2	–	Sell	-41,600	Closed	-$2.47M	–	1148
2023 Q1	$2.47M	Sell	41,600 -36,400	-47%	-$2.02M	0.02%	382
2022 Q4	$3.81M	Sell	78,000 -40,000	-34%	-$1.85M	0.02%	427
2022 Q3	$6.09M	Buy	+118,000	New	+$7M	0.03%	366
2022 Q2	–	Sell	-170,100	Closed	-$14.6M	–	1362
2022 Q1	$14.6M	Buy	+170,100	New	+$14M	0.05%	327
2017 Q4	–	Sell	-15,629	Closed	-$257K	–	1161
2017 Q3	$257K	Buy	+15,629	New	+$265K	﹤0.01%	987
2014 Q4	–	Sell	-195,611	Closed	-$11.6M	–	426
2014 Q3	$11.6M	Buy	+195,611	New	+$10.9M	0.18%	101

Other funds holding THC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Natixis's THC Position: Q1 2026 in Review

Natixis reduced its Tenet Healthcare (THC) stake by 86% in Q1 2026, selling an estimated $5.65M and leaving 4,250 shares worth $802K. The position accounts for ﹤0.01% of the portfolio, ranked #729.

Natixis first reported a position in THC in Q3 2014 and has held it in 11 quarters since. The position peaked at $14.6M in Q1 2022. 693 funds tracked by Wall St. Rank hold THC as of Q1 2026.

Natixis held 4,250 shares of Tenet Healthcare worth $802K as of Q1 2026.
Natixis sold 26,812 Tenet Healthcare shares in Q1 2026, an estimated $5.65M.
Tenet Healthcare made up ﹤0.01% of Natixis's portfolio in Q1 2026, its #729 holding.
Natixis first reported a position in Tenet Healthcare in Q3 2014 and has held it in 11 quarters since.
Natixis's Tenet Healthcare position peaked at $14.6M in Q1 2022.
693 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.

Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.